Standard BioTools (LAB) News Today → Trump convicted... now what? (From Stansberry Research) (Ad) Free LAB Stock Alerts $2.33 +0.01 (+0.43%) (As of 10:07 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 6:42 AM | americanbankingnews.comStandard BioTools (NASDAQ:LAB) Trading Down 6.3%June 7 at 2:45 PM | marketbeat.comStandard BioTools (NASDAQ:LAB) Stock Price Down 6.3%Standard BioTools (NASDAQ:LAB) Trading Down 6.3%June 3, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Shares Gap Down to $2.56Standard BioTools (NASDAQ:LAB) Shares Gap Down to $2.56May 28, 2024 | globenewswire.comStandard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan CustomersMay 23, 2024 | insidertrades.comStandard BioTools Inc. (NASDAQ:LAB) Director Acquires $258,000.00 in StockMay 22, 2024 | marketbeat.comCasdin Partners Master Fund, L Purchases 100,000 Shares of Standard BioTools Inc. (NASDAQ:LAB) StockStandard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L acquired 100,000 shares of the firm's stock in a transaction on Monday, May 20th. The shares were bought at an average price of $2.58 per share, for a total transaction of $258,000.00. Following the completion of the transaction, the director now owns 45,475,821 shares of the company's stock, valued at $117,327,618.18. The transaction was disclosed in a document filed with the SEC, which is available at this link.May 22, 2024 | globenewswire.comStandard BioTools to Participate in Upcoming Investor ConferencesMay 20, 2024 | marketbeat.comStandard BioTools Inc. (NASDAQ:LAB) Shares Purchased by Assenagon Asset Management S.A.Assenagon Asset Management S.A. grew its holdings in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 783.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 578,439 shares of the company's stock after purchasing an additional 512,937May 20, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Shares Gap Up Following Insider Buying ActivityStandard BioTools (NASDAQ:LAB) Shares Gap Up Following Insider Buying ActivityMay 20, 2024 | globenewswire.comStandard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)May 18, 2024 | insidertrades.comStandard BioTools Inc. (NASDAQ:LAB) Director Buys $901,304.32 in StockMay 17, 2024 | marketbeat.comCasdin Partners Master Fund, L Purchases 352,072 Shares of Standard BioTools Inc. (NASDAQ:LAB) StockStandard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L acquired 352,072 shares of Standard BioTools stock in a transaction that occurred on Friday, May 17th. The shares were purchased at an average cost of $2.56 per share, with a total value of $901,304.32. Following the transaction, the director now owns 45,375,821 shares of the company's stock, valued at approximately $116,162,101.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.May 9, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Trading Up 8.5%Standard BioTools (NASDAQ:LAB) Stock Price Up 8.5%May 8, 2024 | investorplace.comLAB Stock Earnings: Standard BioTools Reported Results for Q1 2024May 8, 2024 | globenewswire.comStandard BioTools Reports First Quarter 2024 Financial ResultsMay 1, 2024 | marketbeat.comStandard BioTools (LAB) Set to Announce Quarterly Earnings on WednesdayStandard BioTools (NASDAQ:LAB) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=497828)April 27, 2024 | investing.comStandard BioTools to cut costs with restructuring planApril 26, 2024 | finanznachrichten.deStandard BioTools Inc.: Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthApril 25, 2024 | globenewswire.comStandard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthApril 17, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Sees Large Volume IncreaseStandard BioTools (NASDAQ:LAB) Sees Unusually-High Trading VolumeApril 16, 2024 | msn.comTD Cowen Initiates Coverage of Standard BioTools (LAB) with Buy RecommendationApril 16, 2024 | finance.yahoo.comStandard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic?April 16, 2024 | marketbeat.comTD Cowen Initiates Coverage on Standard BioTools (NASDAQ:LAB)TD Cowen began coverage on Standard BioTools in a report on Tuesday. They set a "buy" rating and a $3.50 price objective on the stock.April 15, 2024 | marketbeat.comStandard BioTools Inc. (NASDAQ:LAB) Sees Significant Increase in Short InterestStandard BioTools Inc. (NASDAQ:LAB - Get Free Report) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 10,230,000 shares, an increase of 10.5% from the March 15th total of 9,260,000 shares. Approximately 2.7% of the shares of the company are short sold. Based on an average daily volume of 2,170,000 shares, the days-to-cover ratio is currently 4.7 days.April 8, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Trading 5.8% Higher Standard BioTools (NASDAQ:LAB) Trading Up 5.8%April 8, 2024 | globenewswire.comStandard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue ImagingApril 5, 2024 | investing.comStandard BioTools secures deal with Bristol Myers SquibbApril 4, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Standard BioTools (LAB)April 4, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Shares Gap Up to $2.66Standard BioTools (NASDAQ:LAB) Shares Gap Up to $2.66April 4, 2024 | marketbeat.comJefferies Financial Group Initiates Coverage on Standard BioTools (NASDAQ:LAB)Jefferies Financial Group started coverage on shares of Standard BioTools in a research report on Thursday. They set a "buy" rating and a $3.25 price objective for the company.April 3, 2024 | globenewswire.comStandard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine ResearchApril 2, 2024 | finance.yahoo.comIs Now The Time To Look At Buying Standard BioTools Inc. (NASDAQ:LAB)?March 29, 2024 | msn.comNikon, Lunaphore team up for spatial biology servicesMarch 21, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Trading 6.9% Higher Standard BioTools (NASDAQ:LAB) Shares Up 6.9%March 20, 2024 | investing.comStandard BioTools swaps preferred for common stockMarch 19, 2024 | finance.yahoo.comEstimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB)March 18, 2024 | msn.comStandard Biotools exchanges all outstanding Series B convertible preferred stock for common stockMarch 18, 2024 | globenewswire.comStandard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common StockMarch 16, 2024 | insidertrades.comStandard BioTools Inc. (NASDAQ:LAB) Director Acquires $642,500.00 in StockMarch 5, 2024 | finance.yahoo.comStandard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | seekingalpha.comStandard BioTools Inc. (LAB) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | finance.yahoo.comStandard BioTools Full Year 2023 Earnings: Revenues Beat Expectations, EPS In LineMarch 1, 2024 | marketbeat.comHighTower Advisors LLC Sells 593,616 Shares of Standard BioTools Inc. (NASDAQ:LAB)HighTower Advisors LLC lessened its holdings in Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 75.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 192,670 shares of the company's stock after selling 593,616February 29, 2024 | finance.yahoo.comQ4 2023 Standard BioTools Inc Earnings CallFebruary 28, 2024 | finance.yahoo.comStandard BioTools Inc (LAB) Reports Growth and Margin Expansion in FY2023 Despite Economic ...February 28, 2024 | globenewswire.comStandard BioTools Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 26, 2024 | finance.yahoo.comStandard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen SequencingFebruary 23, 2024 | marketbeat.comEAM Investors LLC Makes New $1.38 Million Investment in Standard BioTools Inc. (NASDAQ:LAB)EAM Investors LLC bought a new position in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 473,982 shares of the company's stock, valued at aFebruary 22, 2024 | globenewswire.comStandard BioTools to Participate in Upcoming Investor ConferencesFebruary 22, 2024 | benzinga.comStandard BioTools Stock (NASDAQ:LAB), Short Interest Report Get Standard BioTools News Delivered to You Automatically Sign up to receive the latest news and ratings for LAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump convicted... now what? (Ad)Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. But while the Left celebrates his conviction... and the Right rallies around him... the average American is not prepared for what happens next. Which is why it's so important to access this presentation while it's still available online. LAB Media Mentions By Week LAB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LAB News Sentiment▼0.350.76▲Average Medical News Sentiment LAB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LAB Articles This Week▼32▲LAB Articles Average Week Get Standard BioTools News Delivered to You Automatically Sign up to receive the latest news and ratings for LAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Adaptive Biotechnologies News Luna Innovations News Intevac News Sono-Tek News Olink Holding AB (publ) News 10x Genomics News Cytek Biosciences News Quanterix News Pacific Biosciences of California News EyePoint Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LAB) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored